How Has the Barrett's Esophagus Market Evolved Historically and What is its Current Size?
The barrett's esophagus market has seen considerable growth due to a variety of factors.
•The market for barrett's esophagus has seen significant expansion in the past few years. The market, which was worth $6.37 billion in 2024, is projected to rise to $6.73 billion in 2025, with a compound annual growth rate (CAGR) of 5.5%.
Factors contributing to this growth in the past include the rising occurrences of gastroesophageal reflux disease (gerd), an aging population, enhanced awareness and screening programs, the obesity crisis, and the consumption of tobacco and alcohol.
What is the Forecasted Market Size and CAGR for the Barrett's Esophagus Market?
The barrett's esophagus market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for Barrett's esophagus is projected to exhibit robust growth in the coming years, escalating to a value of $8.88 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%.
The anticipated growth over the forecast period is largely due to factors such as genetic and molecular exploration, individualized medication strategies, heightened emphasis on early detection, increasing worldwide healthcare spending, and the incorporation of artificial intelligence. Key trends for this period include cooperative research endeavors, advancements in endoscopy technologies, progress in diagnostic tools, the integration of patient registries, and lifestyle modification programs.
What Are The Primary Growth Drivers In The Barrett's Esophagus Market?
The barrett esophagus market is predicted to experience a boost due to the rising risks of esophageal cancer. Esophageal cancer, a disease that impacts the esophagus (a long, hollow tube linking the throat to the stomach), is on the rise, particularly in patients with Barrett's esophagus accompanied by dysplasia. The odds of this type of cancer are greater in individuals with high-grade dysplasia in Barrett's esophagus. The American Cancer Society, a US-based organization committed to patient support, research, and advocacy for cancer care, estimates that the number of individuals affected by esophageal cancer will increase to 21,560 in the year 2023, up from 20,640 in 2022. Thus, the escalating risk of esophageal cancer is fuelling the growth of the barrett esophagus market.
What Is The Segmentation Of The Global Barrett's Esophagus Market?
The barrett's esophagus market covered in this report is segmented –
1) By Type: No Dysplasia, Low-Grade Dysplasia, High Grade Dysplasia, Other Types
2) By Treatment: Medication, Endoscopic Therapy, Surgery, Other Treatments
3) By Route Of Administration: Oral, Parenteral, Rectal, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
Subsegments:
1) By No Dysplasia: Surveillance Management, Endoscopic Monitoring
2) By Low-Grade Dysplasia: Endoscopic Surveillance, Ablation Therapies
3) By High-Grade Dysplasia: Endoscopic Mucosal Resection (EMR), Radiofrequency Ablation (RFA)
4) By Other Types: Mixed Dysplasia, Rare Variants
Pre-Book The Barrett's Esophagus Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Shaping The Barrett's Esophagus Market Landscape?
The trend of product innovations is currently picking up steam in the barrett esophagus market. The focus of major corporations in the market is on the creation and development of novel, innovative products in order to secure their market position. An example of this is from April 2023, when Laborie Medical Technologies, a medical technology firm based in the US, debuted their alpHaONE wireless pH-capsule reflux testing diagnostic system. The system, designed to diagnose gastroesophageal reflux disease (GERD), offers 96-hour monitoring capabilities, a compact design with enlarged buttons, and a foolproof method for capsule delivery. It's also complimented by a software application featuring a virtual instruction program and buttons for symptoms that can be customized by the user.
Who Are the Key Players in the Barrett's Esophagus Market?
Major companies operating in the barrett's esophagus market include:
• F Hoffmann-La Roche Ltd.
• AstraZeneca plc
• Takeda Pharmaceutical Company Limited
• Medtronic PLC.
• Merck KGaA
• Boston Scientific Corporation
• AdventHealth Medical Group
• Olympus Corporation
• Eisai Co. Ltd.
• Steris plc
• Aurobindo Pharma Limited
• Cook Medical Inc.
• Endo International plc
• Sun Pharmaceutical Industries Limited
• Ironwood Pharmaceuticals Inc.
• Spectrum Health System
• Sebela Pharmaceuticals Inc.
• Phathom Pharmaceuticals Inc.
• EndoGastric Solutions Inc.
• NinePoint Medical Inc.
• Mederi Therapeutics Inc.
• SRS Pharmaceuticals Pvt. Ltd
• Pinnacle Biologics Inc.
• Addex Therapeutics Ltd.
• Johnson & Johnson Private Limited
• SpectraScience Inc.
• Zydus Group
What are the Regional Insights into the Barrett's Esophagus Market?
North America was the largest region in the barrett esophagus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the barrett's esophagus market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
